Research from Nottingham University Business School is one step closer to helping to predict deaths from respiratory diseases by analyzing the shopping habits of customers in local authority areas across England.
Nov 22, 2023
0
18
A Saint Louis University researcher was instrumental in developing the first and only Food and Drug Administration (FDA) approved treatment for agitation associated with Alzheimer's dementia.
Nov 21, 2023
0
48
The long-term use of painkillers from a young age may be linked to an increased risk of poor mental health later in life. This is according to research led by scientists at the University of Liverpool and St George's, University ...
Nov 16, 2023
0
11
Millions of people with normal blood pressure may be misclassified as having blood pressure that is too high because of improper positioning when measurements are taken, new research suggests.
Nov 10, 2023
6
558
Huntington's disease causes involuntary movements and dementia, has no cure, and is fatal. For the first time, UC Riverside scientists have shown they can slow its progression in flies and worms, opening the door to human ...
Nov 8, 2023
0
35
If pharmacists had a larger role in prescribing medications to control blood pressure, they could prevent more than 15 million heart attacks, nearly 8 million strokes and more than 4 million cases each of angina and heart ...
Nov 3, 2023
7
18
A susceptibility to gain weight may be written into molecular processes of human cells, a Washington State University study indicates.
Nov 1, 2023
0
169
Starting buprenorphine treatment for opioid use disorder through telehealth was associated with an increased likelihood of staying in treatment longer compared to starting treatment in a non-telehealth setting, according ...
Oct 18, 2023
0
12
Determining whether a person is diabetic could be as easy as having them speak a few sentences into their smartphone, according to a groundbreaking study from Klick Labs that combines voice technology with artificial intelligence ...
Oct 18, 2023
0
109
After 12 initial weeks of weight loss with intensive lifestyle intervention alone, participants in the SURMOUNT-3 study who were randomly assigned to tirzepatide for 72 weeks achieved a total mean reduction in baseline body ...
Oct 16, 2023
0
30
